A High-Throughput Microbial Viability Assay to Evaluate Lyoprotectants for Live Biotherapeutic Products
Molecular Pharmaceutics · 03.11.2025 · 22 (11) · 6623-6635
DOI: 10.1021/acs.molpharmaceut.5c00557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 22.10.2025. Verfasst von Haixi Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland 21201, United States. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Microbial Viability, Excipients, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Many cell-based therapies, such as live biotherapeutic products (LBPs), require preservation of cell viability during manufacturing, transportation, and storage before being delivered to patients. Although lyophilization is a common strategy to improve storage stability, it can compromise cell viability, thus reducing therapeutic efficacy. To mitigate this challenge, protective excipients, known as lyoprotectants, are necessary to protect cells during lyophilization. While current research centers on a few disaccharides such as trehalose and sucrose, there is a growing need to investigate and screen more alternatives to broaden the range of lyoprotectants and tailor formulations to specific strains. However, conventional methods for cell formulation screening, such as colony-forming assay, despite being considered as the gold standard for evaluating microorganism viability, are labor-intensive and expensive. In this study, we report a high-throughput screening (HTS) method based on well-plates to evaluate lyoprotectants for a representative LBP, BioPYM, a genetically modified Saccharomyces boulardii targeting gastrointestinal diseases. In this assay, various BioPYM formulations were lyophilized on a metal 96-well plate, washed to remove lyoprotectants, and then diluted and inoculated into a nutritional medium for growth monitoring. A significant inverse relationship was observed between log10(cell viability) and growth lag time, with a Pearson's coefficient of -0.9862, suggesting that higher post-lyo viability can be reflected by shorter lag times during recovery growth. Comparable post-lyo viability was observed between well-plate-based lyophilization and bulk-material lyophilization. With this high-throughput method, we expect to boost the range of excipient choices beyond commonly used disaccharides to help cells withstand the stresses of lyophilization and more efficiently customize the protective formulations for cell-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland 21201, United States.
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.
- FZata Inc., Halethorpe, Maryland 21227, United States.
- Department of Microbial Pathogenesis, University of Maryland, Baltimore, Maryland 21201, United States.
ORCID-Profile: Haixi Cui, Stephen W Hoag
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Cui, H., Feng, J. T., Kumari, S., Yu, H., Yu, D., Feng, H., & Hoag, S. W. (2025). A High-Throughput Microbial Viability Assay to Evaluate Lyoprotectants for Live Biotherapeutic Products. Molecular Pharmaceutics, 22(11), 6623-6635. https://doi.org/10.1021/acs.molpharmaceut.5c00557
Vancouver
Cui H, Feng JT, Kumari S, Yu H, Yu D, Feng H, et al. A High-Throughput Microbial Viability Assay to Evaluate Lyoprotectants for Live Biotherapeutic Products. Molecular Pharmaceutics. 2025;22(11):6623-6635. doi:10.1021/acs.molpharmaceut.5c00557
BibTeX
@article{Cui2025,
author = {Cui, Haixi and Feng, Jonathan T and Kumari, Sonali and Yu, Hua and Yu, Di and Feng, Hanping and Hoag, Stephen W},
title = {A High-Throughput Microbial Viability Assay to Evaluate Lyoprotectants for Live Biotherapeutic Products},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {11},
pages = {6623--6635},
doi = {10.1021/acs.molpharmaceut.5c00557}
}
EUVIMED